BEOVU Versus Eylea in the Treatment of Age-related Macular Neovascular Degeneration
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
Age-Related macular neovascularization degeneration occur is a vision threatening condition.
The investigators compare the efficacy of BEOVU and Eylea intravitreal treatment in the
management.